Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Claritas Genomics | RCV000170364 | SCV000222776 | pathogenic | Cockayne syndrome type 2 | 2011-04-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001850424 | SCV002161296 | pathogenic | not provided | 2021-11-26 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 190146). This variant is also known as +T 1359, frameshift 427>435stop. This premature translational stop signal has been observed in individual(s) with Cockayne syndrome (PMID: 9443879). This sequence change creates a premature translational stop signal (p.Ser429Lysfs*7) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). |